Incidence and predictors of silent myocardial infarction in type 2 diabetes and the effect of fenofibrate: an analysis from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
Open Access
- 29 September 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 31 (1) , 92-99
Abstract
To determine the incidence and predictors of, and effects of fenofibrate on silent myocardial infarction (MI) in a large contemporary cohort of patients with type 2 diabetes in the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Routine electrocardiograms taken throughout the study were assessed by Minnesota-code criteria for the presence of new Q-waves without clinical presentation and analysed with blinding to treatment allocation and clinical outcome. Of all MIs, 36.8% were silent. Being male, older age, longer diabetes duration, prior cardiovascular disease (CVD), neuropathy, higher HbA1c, albuminuria, high serum creatinine, and insulin use all significantly predicted risk of clinical or silent MI. Fenofibrate reduced MI (clinical or silent) by 19% [hazard ratio (HR) 0.81, 95% confidence interval (CI) 0.69–0.94; P = 0.006], non-fatal clinical MI by 24% (P = 0.01), and silent MI by 16% (P = 0.16). Among those having silent MI, fenofibrate reduced subsequent clinical CVD events by 78% (HR 0.22, 95% CI 0.08–0.65; P = 0.003). Silent and clinical MI have similar risk factors and increase the risk of future CVD events. Fenofibrate reduces the risk of a first MI and substantially reduces the risk of further clinical CVD events after silent MI, supporting its use in type 2 diabetes.Keywords
This publication has 29 references indexed in Scilit:
- Six‐year follow‐up of a cohort of 203 patients with diabetes after screening for silent myocardial ischaemiaDiabetic Medicine, 2006
- Prevalence of silent myocardial ischaemia in new‐onset middle‐aged Type 2 diabetic patients without other cardiovascular risk factorsDiabetic Medicine, 2006
- Predictive Value of Silent Myocardial Ischemia for Cardiac Events in Diabetic PatientsDiabetes Care, 2005
- Clinically unrecognized Q-wave myocardial infarction in patients with diabetes mellitus, systemic hypertension, and nephropathyThe American Journal of Cardiology, 2004
- Frequency of silent myocardial ischemia in type 2 diabetic patients and the relation with poor glycemic controlActa Diabetologica, 2004
- Silent myocardial infarction and its prognosis in a community-based cohort of Type 2 diabetic patients: the Fremantle Diabetes StudyDiabetologia, 2004
- Silent coronary artery disease in patients with type 2 diabetes mellitusActa Diabetologica, 2003
- Physicians vs PhysiciansArchives of internal medicine (1960), 2001
- Silent coronary artery disease in diabetes - a feature of autonomic neuropathy or accelerated atherosclerosis?Diabetologia, 2001
- Prevalence and prediction of silent ischaemia in diabetes mellitus: a population-based studyCardiovascular Research, 1997